Skip to main content
main-content

Zeitschrift

Clinical and Translational Oncology

Clinical and Translational Oncology 2/2019

Ausgabe 2/2019

Inhaltsverzeichnis ( 15 Artikel )

18.06.2018 | Review Article | Ausgabe 2/2019 Open Access

New horizons in breast cancer: the promise of immunotherapy

L. de la Cruz-Merino, N. Palazón-Carrión, F. Henao-Carrasco, E. Nogales-Fernández, M. Álamo-de la Gala, A. Vallejo-Benítez, M. Chiesa, V. Sánchez-Margalet, GEICAM (Spanish Breast Cancer Research Group) and GÉTICA (Spanish Group for Cancer Immuno-Biotherapy)

27.06.2018 | Review Article | Ausgabe 2/2019

The microRNA signatures: aberrantly expressed miRNAs in prostate cancer

N. Sharma, M. M. Baruah

12.07.2018 | Review Article | Ausgabe 2/2019

Molecular biomarkers for prognosis of gastrointestinal stromal tumor

X. Liu, K.-M. Chu

26.07.2018 | Review Article | Ausgabe 2/2019

Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy

S. Jiang, C. Hu, P. Liu, M. Lu

15.11.2018 | Review Article | Ausgabe 2/2019

Do locally advanced and metastatic human epithelial cancers evolve in ‘placental/decidual-like microenvironments’?

M. Hernández-Bronchud

12.07.2018 | Research Article | Ausgabe 2/2019

CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study

X. Zhang, J. Zhou, D.-D. Zhu, J. Huang, J.-H. Sun, T.-F. Li, C.-S. Shi, Z.-C. Sun, Q.-M. Hou, Z.-Y. Peng, W.-Q. Yu, J.-S. Ji, W.-J. Gu, G.-H. Zhou, X.-X Xie, X.-H. Guo, G.-H. Cao, Z.-H. Yu, H.-H. Xu, J. Fang, S.-H. Ying, W.-H. Hu, W.-B. Ji, J. Han, X. Wu, J.-P. Zheng, J. Luo, Y.-T. Chen, T.-Y. Hu, L. Li, H.-J. Hu, H.-J. Du, G.-L. Shao

06.06.2018 | Research Article | Ausgabe 2/2019

Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation

F. Bartel, M. van Herk, H. Vrenken, F. Vandaele, S. Sunaert, K. de Jaeger, N. J. Dollekamp, C. Carbaat, E. Lamers, E. M. T. Dieleman, Y. Lievens, D. de Ruysscher, S. B. Schagen, M. B. de Ruiter, J. C. de Munck, J. Belderbos

11.06.2018 | Research Article | Ausgabe 2/2019

Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era

M. Marín, C. Gudiol, F. Castet, M. Oliva, I. Peiró, C. Royo-Cebrecos, J. Carratalà, R. Mesia

11.06.2018 | Research Article | Ausgabe 2/2019

Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma

L.-L. Deng, H.-B. Deng, C.-L. Lu, G. Gao, F. Wang, Y. Yang

13.06.2018 | Research Article | Ausgabe 2/2019

The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study

T. Karantanos, S. Karanika, B. Seth, G. Gignac

25.06.2018 | Research Article | Ausgabe 2/2019

The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients

H. Shuang, J. Feng, C. Caineng, J. Qifeng, J. Tin, C. Yuanyuan, C. Xiaozhong

28.06.2018 | Research Article | Ausgabe 2/2019

iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of β-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer

G. Liu, F. Fei, J. Qu, X. Wang, Y. Zhao, Y. Li, S. Zhang

02.07.2018 | Research Article | Ausgabe 2/2019

Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification

J. Wei, T. Yao, Y. Wang, L. Li, C. Pan, N. Zhang

28.06.2018 | Brief Research Article | Ausgabe 2/2019

Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial

O. Abdel-Rahman

10.07.2018 | Correspondence | Ausgabe 2/2019

Controversies in the management of stage I seminoma: adjuvant carboplatin revisited

J. Aparicio, J. Terrasa, the Spanish Germ Cell Cancer Group

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise